FOXP3
Forkhead box protein P3
Also known as: AIID, DIETER, FOXP3_HUMAN, IPEX, JM2, PIDX, SCURFIN, XPID
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BZS1
- Gene
- FOXP3
- Ensembl
- ENSG00000049768
- Chromosome
- X
- Canonical length
- 431 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the forkhead/winged-helix family of transcriptional regulators. Defects in this gene are the cause of immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX), also known as X-linked autoimmunity-immunodeficiency syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
431 residues, UniProt reviewed canonical sequence.
>Q9BZS1|FOXP3
1 MPNPRPGKPS APSLALGPSP GASPSWRAAP KASDLLGARG PGGTFQGRDL RGGAHASSSS
61 LNPMPPSQLQ LPTLPLVMVA PSGARLGPLP HLQALLQDRP HFMHQLSTVD AHARTPVLQV
121 HPLESPAMIS LTPPTTATGV FSLKARPGLP PGINVASLEW VSREPALLCT FPNPSAPRKD
181 STLSAVPQSS YPLLANGVCK WPGCEKVFEE PEDFLKHCQA DHLLDEKGRA QCLLQREMVQ
241 SLEQQLVLEK EKLSAMQAHL AGKMALTKAS SVASSDKGSC CIVAAGSQGP VVPAWSGPRE
301 APDSLFAVRR HLWGSHGNST FPEFLHNMDY FKFHNMRPPF TYATLIRWAI LEAPEKQRTL
361 NEIYHWFTRM FAFFRNHPAT WKNAIRHNLS LHKCFVRVES EKGAVWTVDE LEFRKKRSQR
421 PSRCSNPTPG PLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FOXP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 6.6 nTPM
Expression across tissuesHPA
Tissue
- appendix: 6.6 nTPM
- thymus: 6.3 nTPM
- lymph node: 5.3 nTPM
- epididymis: 4.9 nTPM
- tonsil: 4.7 nTPM
- urinary bladder: 2.6 nTPM
Single-cell type
- t-cells: 9.2 nCPM
- epididymal principal cells: 4 nCPM
- undifferentiated spermatogonia: 1.7 nCPM
- early primary spermatocytes: 1.6 nCPM
- thymic myoid cells: 1.4 nCPM
- hepatocytes: 1.1 nCPM
Immune cell
- T-reg: 52 nTPM
- memory CD4 T-cell: 4.6 nTPM
- total PBMC: 1.5 nTPM
- naive CD4 T-cell: 0.9 nTPM
- MAIT T-cell: 0.2 nTPM
- memory CD8 T-cell: 0.2 nTPM
Brain region
- cerebellum: 3.1 nTPM
- amygdala: 2.3 nTPM
- medulla oblongata: 2.2 nTPM
- hippocampal formation: 2.1 nTPM
- basal ganglia: 2 nTPM
- cerebral cortex: 2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FOXP3.
Disease | AllUniProt
Conditions FOXP3 is implicated in, by any mechanism.
- Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) MIM:304790
Disease | GeneticClinVar
58 pathogenic / likely-pathogenic of 475 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Insulin-dependent diabetes mellitus secretory diarrhea syndrome
- FOXP3-related disorder
- Hydrops fetalis
- Non-obstructive azoospermia
- Neurodevelopmental disorder
Disease | ImmuneIEDB
Conditions an epitope on FOXP3 was assayed in.
- breast cancer T cell
ReferencesPubMed · IEDB
Publications for FOXP3 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
6 publications
- Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma.
2013 · Tumour Biol · RCR 0.9 · 24 citations - Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer.
2018 · Sci Rep · RCR 0.4 · 10 citations - Study of circulating antibodies against CD25 and FOXP3 in breast cancer.
2014 · Tumour Biol · RCR 0.3 · 9 citations - FOXP3 autoantibody as a potential early prognostic serum biomarker in patients with cervical cancer.
2015 · Int J Clin Oncol · RCR 0.2 · 6 citations - Further Study of Circulating Antibodies to P16, CD25 and FOXP3 in Hepatocellular Carcinoma.
2019 · Onco Targets Ther · RCR 0.2 · 5 citations
Show 1 more
- Radiobinding assay for detecting autoantibodies to single epitopes.
2008 · J Immunol Methods · RCR 0.1 · 4 citations
Reference: B cellIEDB
1 publication
- Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody.
2019 · Oncoimmunology · RCR 0.7 · 21 citations
Reference: T cellIEDB
1 publication
- Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma.
2020 · Oncoimmunology · RCR 2.1 · 35 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.2
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 1.67
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell homeostasis
- CD4-positive, alpha-beta T cell proliferation
- CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment
- chromatin remodeling
- establishment of endothelial blood-brain barrier
- immature T cell proliferation in thymus
- inflammatory response
- isotype switching to IgE isotypes
- myeloid cell homeostasis
- negative regulation of activated T cell proliferation
- negative regulation of CD4-positive, alpha-beta T cell proliferation
- negative regulation of cell population proliferation
- negative regulation of chronic inflammatory response
- negative regulation of CREB transcription factor activity
- negative regulation of cytokine production
- negative regulation of defense response to virus
- negative regulation of DNA-binding transcription factor activity
- negative regulation of DNA-templated transcription
- negative regulation of immune response
- negative regulation of interleukin-10 production
- negative regulation of interleukin-17 production
- negative regulation of interleukin-2 production
- negative regulation of interleukin-4 production
- negative regulation of interleukin-5 production
- negative regulation of interleukin-6 production
- negative regulation of isotype switching to IgE isotypes
- negative regulation of NF-kappaB transcription factor activity
- negative regulation of T cell cytokine production
- negative regulation of T cell proliferation
- negative regulation of T-helper 17 cell differentiation
- negative regulation of tumor necrosis factor production
- negative regulation of type II interferon production
- positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation
- positive regulation of DNA-templated transcription
- positive regulation of immature T cell proliferation in thymus
- positive regulation of interleukin-4 production
- positive regulation of regulatory T cell differentiation
- positive regulation of T cell anergy
- positive regulation of transcription by RNA polymerase II
- positive regulation of transforming growth factor beta1 production
- regulation of DNA-templated transcription
- regulation of isotype switching to IgG isotypes
- regulation of T cell anergy
- regulation of transcription by RNA polymerase II
- regulatory T cell differentiation
- response to lipopolysaccharide
- response to rapamycin
- response to virus
- T cell activation
- T cell anergy
- T cell homeostasis
- T cell mediated immunity
- T cell receptor signaling pathway
- tolerance induction to self antigen
- transcription by RNA polymerase II
- transforming growth factor beta1 production
- positive regulation of peripheral T cell tolerance induction
Molecular functions
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- histone acetyltransferase binding
- histone deacetylase binding
- NF-kappaB binding
- NFAT protein binding
- protein homodimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- transcription corepressor activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FOXP3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FOXP3 as an antibody target. Whether an autoantibody or antibody against FOXP3 could matter depends on whether native FOXP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FOXP3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FOXP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...